Ipamorelin

Shop Ipamorelin
Code ths10 applied at checkout

Also called: GHRP, Ipamorelin and CJC-1295, Ipamorelin and CJC-1295 without DAC

By The Health Stacks Research TeamUpdated September 16, 2026

Ipamorelin is a man-made peptide, which is a tiny chain of building blocks called amino acids. It is a copy of a natural body chemical called ghrelin, which is sometimes called the hunger hormone. Ipamorelin is sold as a white powder for lab studies. It is not an approved medicine. Companies sell it to researchers, and some people seek it out hoping it will help with muscle, recovery, and aging.

Ipamorelin tells the pituitary gland, a small gland in the brain, to let out growth hormone. Growth hormone helps the body build muscle and repair itself. Ipamorelin does this by attaching to a special docking spot on the gland's cells called the ghrelin receptor. This makes growth hormone come out in short bursts, much like the body does on its own. It is known for being very selective, meaning it raises growth hormone without raising other stress hormones.

There is still a lot we do not know. Most studies have been done in animals or in labs, not in large human trials. It is not approved by the FDA, so its safety and long-term effects in people are unclear. Some other similar peptides raise prolactin and cortisol, but ipamorelin causes little of this rise. Anyone thinking about using it should know it is meant for laboratory research only, and using unapproved injectable compounds carries real risks.

Research-stageEarly-stage — evidence so far is mostly cell, animal, or preliminary human studies. Not an approved medicine. High confidence60–79 — backed by solid sources with good corroboration across multiple citations.

Building Blocks

Ipamorelin in Stacks & Blends

Ipamorelin is one of the building blocks in this blend or stack people actually buy:

Benefits

What Ipamorelin Helps With

The main themes across 17 research studies, in plain language.

Musculoskeletal

Muscle growth & lean mass

40/100Rated 40/100Source typeVendor / seller pageIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 18 underlying claims

Studies indicate that increased growth hormone levels may support the development of lean muscle mass and improve overall body composition.

Research examplesBest source ↗

Bone density & skeletal health

40/100Rated 40/100Source typeVendor / seller pageIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 16 underlying claims

Evidence suggests that stimulation of growth hormone pathways may support bone mineralization, increase bone density, and promote skeletal growth.

Research examplesBest source ↗

Reproductive & hormonal

Selective growth hormone release

50/100Rated 50/100Source typeUnclassified sourceIndependent sources7Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 42 underlying claims

Research suggests that this peptide stimulates the release of growth hormone in a pulsatile manner, mimicking natural patterns, without significantly elevating stress hormones like cortisol or prolactin.

Research examplesBest source ↗

Safety & hormonal specificity

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Studies highlight a favorable safety profile, noting that the peptide selectively targets growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels.

Research examplesBest source ↗

Tissue repair & recovery

40/100Rated 40/100Source typeVendor / seller pageIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 15 underlying claims

Research indicates that growth hormone release may accelerate the repair of damaged tissues, reduce muscle soreness, and support post-exercise recovery.

Research examplesBest source ↗

Gastrointestinal motility

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Evidence points to prokinetic properties that may accelerate gastric emptying and improve the movement of contents through the digestive tract.

Research examplesBest source ↗

Fat metabolism & weight management

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 18 underlying claims

Research points to a potential role in promoting lipid breakdown and reducing adipose tissue, which may aid in fat loss and weight management.

Research examplesBest source ↗

Metabolic & insulin sensitivity

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Findings imply that therapy may help regulate blood sugar levels and improve insulin sensitivity, though individual responses can vary.

Research examplesBest source ↗

Cardiovascular & vasculature support

30/100Rated 30/100Source typeForum or blogIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 2 underlying claims

Limited evidence suggests potential benefits for vascular health and improved blood flow, possibly linked to nitric oxide or metabolic changes.

Research examplesBest source ↗

Neuroprotection & cognitive function

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 9 underlying claims

Preliminary studies indicate potential neuroprotective benefits and improvements in cognitive function, possibly mediated through BDNF or other pathways.

Research examplesBest source ↗

Anti-aging & cellular longevity

30/100Rated 30/100Source typeForum or blogIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Research suggests that cellular repair mechanisms and optimized hormone levels may contribute to anti-aging benefits and overall vitality.

Research examplesBest source ↗

Collagen synthesis & skin health

50/100Rated 50/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 10 underlying claims

Studies suggest that enhanced growth hormone levels may stimulate collagen production, potentially improving skin elasticity and connective tissue health.

Research examplesBest source ↗

Sleep quality & architecture

50/100Rated 50/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 16 underlying claims

Findings imply that therapy may improve sleep quality by increasing slow-wave (deep) sleep duration and reducing the time it takes to fall asleep.

Research examplesBest source ↗

Vitality, energy & mood

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 8 underlying claims

Anecdotal reports and some studies suggest that users may experience improved energy levels, reduced anxiety, and an enhanced sense of well-being.

Research examplesBest source ↗

Synergy & combination therapy

40/100Rated 40/100Source typeVendor / seller pageIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 7 underlying claims

Research suggests that combining this peptide with other agents (like GHRH analogs) may create synergistic effects, amplifying growth hormone release.

Research examplesBest source ↗

Free: The Peptide Stack Cheat-Sheet

See where Ipamorelin fits — the most-used combinations, dosing notes from the research, and what to check before you buy.

No spam. Unsubscribe anytime.

How People Use It

1 reported routine — each line links to the source it came from.

Self-reported & vendor-suggested

Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.

General

  • 100–250 mcg once daily SC (research: 100–300 mcg 2–3×/day) 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
    1. Weeks 1–2 — 100 mcg · 6 units (0.06 mL)
    2. Weeks 3–4 — 150 mcg · 9 units (0.09 mL)
    3. Weeks 5–8 — 200 mcg · 12 units (0.12 mL)
    4. Weeks 9–12 — 250 mcg · 15 units (0.15 mL)

mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.

Honest expectations

What Ipamorelin doesn’t do

What the sourced research says it doesn’t do — as notable as what it does.

Safety

Known Side Effects

Adverse effects reported in the research and by community use.

  • Lack of Cortisol/ACTH ElevationMild 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pubmed.ncbi.nlm.nih.gov
  • Interaction with Adrenergic BlockersModerate 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pubmed.ncbi.nlm.nih.gov
  • Altered Efficacy in Diabetic StatesMild 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pubmed.ncbi.nlm.nih.gov
  • Serious adverse events including death (ipamorelin, IV)LifeThreatening 90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
  • Intense hungerMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Cortisol elevationModerate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Flushing or warmthMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
  • Mild water retention and transient flushing (ipamorelin)Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
  • Ipamorelin: mild, transient water retention, temporary flushing, and minimal appetite stimulationMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com

Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.

Get Ipamorelin

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Shop Ipamorelin
Code ths10 applied at checkout
Technical Details (sequence & mechanism — click to expand)

Amino Acid Sequence

Ipamorelin9 residues
A
H
D
N
D
P
L
N
H
Hydrophobic Acidic Basic Polar Aromatic

Mechanism of Action

Ipamorelin is a synthetic pentapeptide, a third-generation growth hormone releasing peptide (GHRP) and selective agonist of the ghrelin/growth-hormone secretagogue receptor (GHS-R) on pituitary somatotropes. It stimulates pulsatile GH release while having minimal effect on ACTH, cortisol, or prolactin - the first relatively selective GH secretagogue. It is not FDA-approved.

Evidence

Research Citations (8)

Every claim above traces back to a source you can check — here are 8 of them.

  • Ipamorelin, the first selective growth hormone secretagogue.

    AnimalStudy1998 Key study 84/100Rated 84/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Ipamorelin for post-operative ileus (NCT00672074)

    Registry2014 78/100Rated 78/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

    1999 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

    1999 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.

    2014 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Ipamorelin

    72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats.

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Ipamorelin | C38H49N9O5 | CID 9831659 - PubChem

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

Timeline

History & Milestones

Key moments in Ipamorelin’s research and regulatory timeline — sourced and dated.

  1. Ipamorelin, the first selective growth hormone secretagoguePublicationNov 1, 1998
    Related:Ipamorelin
    84/100Rated 84/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

News

Latest on Ipamorelin

Dated, sourced reporting that mentions Ipamorelin.

ConsumerNov 15, 2025

CNN investigation: wellness influencers drive boom in unapproved "research-use-only" peptides

A November 2025 CNN report documents how celebrities and wellness influencers are fueling mass consumer use of unapproved peptides like BPC-157, TB-500, ipamorelin, and CJC-1295, many sold with a "for research use only" label that lawyers and regulators describe as a loophole to evade FDA oversight. Health Secretary Robert F. Kennedy Jr. has vowed to end the agency's "war on peptides," while named sellers such as biohacker Gary Brecka market injectable vials for $350 to $600 each. Independent experts — including Scripps' Dr. Eric Topol and UC Davis biologist Paul Knoepfler — stress that none of these compounds have passed adequate clinical trials and that "research-grade" powders often contain contaminants. BPC-157 and TB-500 are also banned by international sports authorities as doping substances.

72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Regulatory

NuScience Peptides LLC

The FDA issued a warning letter to NuScience Peptides LLC for marketing unapproved injectable peptide drugs, including GLP-1/GLP-2/GLP-3 products and other peptides, on its website. The agency determined these products are unapproved new drugs under the FD&C Act. FDA warned that failure to correct the violations could lead to seizure or injunction.

95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Regulatory

NZR Anti-Doping Tribunal Decision PLAYER A

The New Zealand Rugby Anti-Doping Judicial Committee decision records Customs-intercepted mail containing, among other items, Biotech peptides, CJC-1295 (ipamorelin) 5/5mg, 3 x vials — a single combination vial naming both peptides, which the committee lists as a prohibited non-specified substance. The source labels the vial CJC-1295 (ipamorelin) without further DAC qualification; it is attributed to the with-DAC compound because unqualified CJC-1295 denotes the DAC form. A recreational athlete received a two-year sanction (backdated to provisional suspension on 9 August 2023) for importing and using the prohibited substances.

90/100Rated 90/100Source typeRegulator or clinical registryIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Regulatory

Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

FDA's running list of bulk drug substances that present significant safety risks in compounding names GHRP-2, GHRP-6, ipamorelin acetate, CJC-1295 and AOD-9604. GHRP-2 and GHRP-6 were added to the 503B risk list on September 29, 2023 over immunogenicity concerns, and FDA notes serious adverse events for CJC-1295 (increased heart rate, systemic vasodilatory reactions). The list confirms these peptides are treated by FDA as unsafe-for-compounding substances.

90/100Rated 90/100Source typeRegulator or clinical registryIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
Regulatory

Tailor Made Compounding LLC

FDA warned Tailor Made Compounding LLC (Nicholasville, KY) after a 2018 inspection found it compounded drug products with bulk substances ineligible for 503A exemptions. The letter explicitly lists the compounded substances: Follistatin, GHRP-2, GHRP-6, AOD 9604, BPC 157, Bremelanotide (PT-141), Cerebrolysin, DSIP, Epitalon, GHK-Cu, Ipamorelin, LL-37, Melanotan II, Selank, Semax, and CJC 1295, among others. The firm was cited for insanitary aseptic processing (adulteration), unapproved new drugs, and misbranding, and removed GHRP-2 and GHRP-6 from its formulary in response.

90/100Rated 90/100Source typeRegulator or clinical registryIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →

Wondering how Ipamorelin pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Related on The Health Stacks

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.